OKYO Pharma Ltd ADR (OKYO) — Cash Flow-to-Debt Ratio
OKYO Pharma Ltd ADR (OKYO) has a Cash Flow-to-Debt Ratio of -0.19x as of September 2025, meaning its operating cash flow of $-1.53 Million could theoretically repay 0% of its total liabilities ($8.06 Million) in one year. See OKYO Pharma Ltd ADR working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
OKYO Pharma Ltd ADR Cash Flow-to-Debt Ratio (2008–2025)
Historical debt coverage capacity for OKYO Pharma Ltd ADR across 18 annual periods. Also explore OKYO year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for OKYO Pharma Ltd ADR (2008–2025)
Year-by-year debt coverage analysis for OKYO Pharma Ltd ADR. For market capitalisation and broader financial context, see market value of OKYO Pharma Ltd ADR.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.20x | $-1.81 Million | $9.23 Million | ▲ +84.7% |
| 2024 | -1.28x | $-9.49 Million | $7.42 Million | ▼ -20.6% |
| 2023 | -1.06x | $-7.70 Million | $7.26 Million | ▲ +73.8% |
| 2022 | -4.04x | $-5.47 Million | $1.35 Million | ▼ -347.4% |
| 2021 | -0.90x | $-1.60 Million | $1.77 Million | ▲ +44.6% |
| 2020 | -1.63x | $-1.20 Million | $737.20K | ▲ +65.0% |
| 2019 | -4.66x | $-1.99 Million | $426.72K | ▲ +73.4% |
| 2018 | -17.51x | $-1.59 Million | $91.06K | ▼ -595.9% |
| 2017 | -2.52x | $-651.27K | $258.76K | ▲ +29.9% |
| 2016 | -3.59x | $-650.88K | $181.34K | ▲ +61.7% |
| 2015 | -9.38x | $-1.42 Million | $151.07K | ▲ +32.6% |
| 2014 | -13.93x | $-3.45 Million | $247.95K | ▲ +33.2% |
| 2013 | -20.85x | $-3.82 Million | $183.32K | ▼ -271.7% |
| 2012 | -5.61x | $-4.67 Million | $832.89K | ▲ +66.3% |
| 2011 | -16.63x | $-1.31 Million | $78.74K | ▼ -51.2% |
| 2010 | -11.00x | $-878.61K | $79.87K | ▼ -317.7% |
| 2009 | -2.63x | $-226.35K | $85.96K | ▲ +25.8% |
| 2008 | -3.55x | $-513.95K | $144.86K | — |